ISIsaura Pilar Sánchez

Isaura Pilar Sánchez

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Isaura Pilar Sánchez has a total of 91 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Cellular Immune Response Induced by mRNA Vaccines Against SARS‐CoV‐2

    by Valentina Tovar, Isaura Pilar Sánchez, María Teresa Rugeles, Natalia Andrea Taborda, Juan C. Hernandez

    The disease caused by SARS‐CoV‐2 is known as COVID‐19, and it can range from mild symptoms to severe clinical manifestations, including respiratory failure, pneumonia, and organ failure. Since its emergence in 2019, more than 7 million deaths have been reported worldwide. Vaccines have been the most effective strategy for preventing severe illness and death in patients who acquire the infection. Vaccines induce both humoral and cell‐mediated immune responses; the latter is crucial in the immune response against SARS‐CoV‐2, as the effector mechanisms of T‐cells are less affected by the high mutation rate of the virus and prevail through memory phenotypes, ensuring long‐term protection. mRNA vaccines have been primarily used worldwide to control the COVID‐19 pandemic. This platform can protect against different circulating variants and is characterized by generating a robust T‐cell response. This review discusses the immune response of T‐cells induced by mRNA vaccines against SARS‐CoV‐2. It explores their effect on different population groups, including people with special clinical conditions, such as cancer and organ transplant recipients with a compromised immune system.


  • Percentages of Effector Memory T Cells in Peripheral Blood Associated With Non‐Infectious Comorbidities in Common Variable Immunodeficiency Disorders

    by Jesús A. Álvarez‐Álvarez, Estefanía Vásquez‐Echeverri, Isaura P. Sánchez, Sebastián Gutierrez Hincapié, Alejandro Gallon Duque, Rubén D. Gómez‐Arias, Julio C. Orrego Arango, José L. Franco, Claudia M. Trujillo‐Vargas

    Common variable immunodeficiency disorders (CVID) are characterized by hypogammaglobulinemia and increased susceptibility to infections. However, non‐infectious comorbidities (NICM) are also frequent manifestations of the disease. We search for distinctive immunophenotypes in CVID patients with NICM. Data were obtained from the clinical records and laboratory analyses of 42 CVID patients. Descriptive statistics, median comparisons, bivariate and multivariate analysis were performed. Median comparison of the immunological variables among patients with or without NICM revealed significant decreased levels of serum IgG, percentages of naïve CD4+ and CD8+ T cells, total B cells and CD56dim NK cells in peripheral blood from CVID patients with NICM together with an increase in the percentages of effector memory (EM) CD4+ and terminally differentiated effector memory (EMRA) CD8+ T cells. By using logistic regressions, we determined the likelihood of exhibiting blood immunological abnormalities in patients with NICM vs. those without NICM. Finally, discriminant analyses and ROC curves established that percentages of CD4+ EM T cells and CD8+ EMRA T cells > 47.4% and 40.2% from the total CD4+ or CD8+ T cells, respectively, might be associated with NICM in CVID. These differences were also observed in CVID patients with Polyclonal lymphocytic infiltration. These data suggest subpopulations of effector T cells as potential biomarkers of NICM in CVID. Prospective studies are needed to determine the usefulness of our findings in the prognosis of CVID.


  • Open Access

    Primer estudio piloto para el tamizaje neonatal de linfopenias T y B en Colombia

    by Sebastián Gutiérrez-Hincapié, Carlos Muskus-López, Isaura Pilar Sánchez, José Luis Franco-Restrepo, Claudia M. Trujillo-Vargas

    Introducción. La detección temprana de linfopenias congénitas facilitaría su tratamiento oportuno y la prevención de complicaciones serias, y optimizaría los recursos del sistema de salud.Objetivo. Realizar un estudio piloto para el tamizaje neonatal de linfopenias mediante la cuantificación de los círculos de escisión (TREC y KREC) de los receptores de los linfocitos T y B en muestras de sangre periférica de neonatos de Medellín, Colombia.Materiales y métodos. Se recolectaron muestras de 1.092 neonatos y de seis pacientes con sospecha de linfopenia, mediante pinchazo del talón o del dedo gordo del pie. Se extrajo el ADN y se midieron los niveles de TREC y KREC por qPCR. Resultados. En los seis pacientes con sospecha de linfopenia se encontraron niveles muy bajos o indetectables de TREC. Todos los neonatos tamizados presentaron niveles normales de TREC y KREC. Se observó concordancia entre los valores de TREC o de KREC en dos tipos diferentes de papel de filtro. Los niveles de TREC y KREC disminuyeron considerablemente después de 24 semanas de almacenamiento de las muestras de sangre en papel de filtro. Se encontró una asociación positiva entre los niveles de los TREC y el peso al nacer, y una correlación negativa entre los KREC y la edad gestacional. Los niveles de estos marcadores no se asociaron con el tipo de parto.Conclusiones. Se presenta el primer estudio piloto para el tamizaje temprano de linfopenias congénitas en neonatos en Colombia. Se propone el uso de un límite de detección de 119 y 69 copias/μl de sangre de TREC y KREC, respectivamente, para futuros programas de detección neonatal de linfopenias en el país.


  • Open Access

    Diagnóstico molecular de SARS-CoV-2 en habitantes de cuatro municipios de Córdoba, Colombia, 2022

    by Erica T Loaiza1, Isaura P Sánchez, Lina M Yassin, José F. Tovar-Valle4

    Objetivo. Evaluar la incidencia y prevalencia de la infección por SARS-CoV-2 en municipios aislados de Córdoba, Colombia, y desarrollar capacidades de diagnóstico mediante PCR en tiempo real más eficiente. Materiales y métodos. Estudio descriptivo transversal en cuatro municipios de Córdoba, utilizando muestras de hisopados nasofaríngeos/orofaríngeos y un kit de detección de PCR en tiempo real. Análisis estadístico para describir características de la población y determinar asociaciones. Resultados. Muestras de 18,079 personas se obtuvieron, principalmente en Sahagún. El 2,2% fue positivo para SARS-CoV-2. Cerca del 50% de los muestreados tenía entre 18 y 49 años, mayormente mujeres rurales y sin pertenencia étnica establecida. Conclusiones. El estudio proporciona información sobre incidencia y prevalencia de la infección por SARS-CoV-2 en municipios aislados de Córdoba, Colombia. Destaca la importancia de desarrollar capacidades de diagnóstico más eficientes. Hallazgos guiarán estrategias de control y prevención en estas áreas. Fundamentales herramientas de diagnóstico y vigilancia para enfrentar futuras pandemias.

  • Open Access

    Relación entre la composición de la microbiota y la hipertensión arterial esencial. Una revisión narrativa

    by Sebastián Rosario-Castro, Daniela Rojas-García, Isaura Pilar Sánchez

    La hipertensión arterial esencial es una patología de alta prevalencia a nivel mundial, y uno de los determinantes más significativos para enfermedad cardiovascular. Por otra parte, se ha generado un gran interés por la microbiota del cuerpo, y la forma en que se ve alterada por factores tanto internos como externos, ocasionando disbiosis. En la actualidad se viene estudiando el efecto de la microbiota en diferentes enfermedades, entre ellas, la relación entre la microbiota y la hipertensión. En este artículo se hizo una revisión de la literatura, entre 2010 a 2021, con el objetivo de identificar la evidencia científica que sustenta la relación entre la composición de la microbiota y la hipertensión arterial esencial. Se encontró en muchos estudios que los hipertensos tenían una diversidad menor de la microbiota, en comparación con los grupos de control sanos. En los hipertensos se encontraron principalmente bacterias del género Prevotella y en el grupo control predominaba el género Bacteroidetes. Adicionalmente, se observó una disminución de Faecalibacterium, Roseburia y Bifidobacterium en el grupo de hipertensos. Existen varias técnicas de laboratorio para el reconocimiento de la población bacteriana del intestino, tales como la secuenciación de la subunidad de ARNr 16S, la secuenciación del genoma completo y la metagenómica de la microbiota. A pesar de que los estudios realizados sobre la relación microbiota e hipertensión concluyen que existe una relación significativa entre ambas, es necesario hacer más investigaciones en diferentes grupos poblacionales.


  • Open Access

    Caracterización clínica y sociodemográfica de pacientes con VIH con síndrome inflamatorio de reconstitución inmune, Antioquia – Colombia

    by Salomon Gallego-Quintero, Ana María Patiño-Isaza, Daniela Lucía Florez-Restrepo, Dione Benjumea-Bedoya, Isaura Pilar Sanchez, Esteban Villegas-Arbeláez, Sofía Giraldo-Hoyos, Jorge Humberto Botero-Garcés, Natalia Andrea Taborda-Vanegas, Juan Carlos Alzate-Ángel

    Background: Despite combined antiretroviral therapy effectiveness for the control of HIV infection, 15-30% of these patients develop Immune Reconstitution Inflammatory Syndrome (IRIS), consisting in a clinical worsening at the beginning of combined Antiretroviral Therapy (cART). It is important to know the prevalence and characteristics of people with IRIS to generate prevention strategies. Objective: To describe the prevalence and sociodemographic characteristics of patients with IRIS HIV-related, from a health care facility in Antioquia - Colombia. Methods: In a population of 515 patients that started cART between 2.013-2.018, we developed a cross-sectional study with a simple random sampling of 188 HIV patients. The presence of IRIS was defined according to French criteria or high suspected IRIS in those who had insufficient clinical information and have developed an opportunistic infection (OI) after cART initiation. Results: The prevalence of IRIS was 12,8% (12,5% by French criteria and 87,5% by high suspected IRIS). IRIS patients were 25% women, median age 41,5 years. 87,5% presented OI. From these, the most common was tuberculosis disease (72,7%). Conclusions: In the era of cART, there are still an important number of IRIS cases, which indicates the need to continue implementing preventive and diagnostic protocols and early treatment initiation.

  • Tamización neonatal y su impacto en la detección temprana de linfopenias congénitas y otras enfermedades raras

    by Isaura Pilar Sánchez, Corporación Universitaria Remington, Natalia Amariles, Andrés A. Arias, Mónica L. Giraldo, Enrique María Velásquez-Velásquez, Augusto Quevedo Vélez, José L. Franco, Claudia M. Trujillo-Vargas, Universidad De Antioquia

  • A Novel Pathogenic Variant in PRF1 Associated with Hemophagocytic Lymphohistiocytosis

    by Camilo Andrés Pérez Romero, Isaura Pilar Sánchez, Sebastian Gutierrez-Hincapié, Jesús A. Álvarez-Álvarez, Jaime Andres Pereañez, Rodrigo Ochoa, Carlos Enrique Muskus-López, Ruth G. Eraso, Carolina Echeverry, Catalina Arango, et al.

    Familial Hemophagocytic Lymphohistiocytosis type 2 (FHL2) results from mutations in PRF1. We described two unrelated individuals who presented with FHL, in whom severely impaired NK cytotoxicity and decrease perforin expression was observed. DNA sequencing of PRF1 demonstrated that both were not only heterozygous for the p.54R > C/91A > V haplotype but also presented with the novel variant p.47G > V at the perforin protein. Perforin mRNA was found to be increased in a individual with that genotype. A carrier of the novel variant also demonstrated altered perforin mRNA and protein expression. Phylogenetic analysis and multiple alignments with perforin orthologous demonstrated a high level of conservation at Gly47. PolyPhen-2 and PROVEAN predicted p.47G > V to be “probably damaging” and “deleterious”, respectively. A thermodynamic analysis showed that this variant was highly stabilizing, decreasing the protein internal energy. The ab initio perforin molecular modeling indicated that Gly47 is buried inside the hydrophobic core of the MACPF domain, which is crucial for the lytic pore formation and protein oligomerization. After the in silico induction of the p.47G > V mutation, Val47 increased the interactions with the surrounding amino acids due to its size and physical properties, avoiding a proper conformational change of the domain. To our knowledge, this is the first description supporting that p.47G > V is a pathogenic variant that in conjunction with p.54R > C/91A > V might result in the clinical phenotype of FHL2.


  • Open Access

    Pilot study for the neonatal screening of congenital T cell lymphopenias

    by Sánchez Isaura, Franco Jose, Arias Andres, Orrego Julio, Giraldo Mónica, Gutierrez Hincapie Sebastian, Rojo Frank, Velásquez Enrique, Quevedo Augusto, Condino-Neto Antonio, et al.

    Introduction: T-cell lymphopenias involved at least 24 conditions characterized by a marked decrease or absence of T lymphocytes in peripheral blood (PB). The frequency of these diseases vary from 1:3000 live births for DiGeorge Syndrome (DGS, the most common cause of T-cell lymphopenia) to 1:33.000 for Severe Combined Immunodeficiency (SCID), the most life-threatening T-cell lymphopenia. Although SCID and other severe T cell lymphopenias fulfill the requirements to be included in newborn screening (NBS) programs, these are performed neither worldwide nor in Colombia. T-cell lymphopenias NBS would allow promptly intervention of such conditions through haematopoietic stem cell transplantation (HSCT), preventing severe infections, organ damage, long hospitalization periods, expensive medication and death, which cause tremendous costs for our health care system. T-cell lymphopenias NBS can be easily implemented by quantifying T-cell receptor excision circles (TRECs). The main goal from our study is to lead the implementation of a NBS program for T-cell lymphopenias in Medellín, and at long term, to shape a laboratory network for the prenatal and neonatal diagnosis of these conditions in Colombia based in formally established public health acts about the issue. Methods: This pilot study will conform a network for sample collection with several Medellín Neonatology Units. Quantification of TRECs will be perform by real-time quantitative polymerase chain reaction (qPCR) using DNA isolated from filter paper dried blood spots collected from the heel of 100 newborns. Results: Our proposal was well received by five neonatologist units from Medellin and we are currently applying for the IRB approval. We have also advanced in comparing the TRECs costs using commercial kits with available research-used-only (RUO) reagents already established for the NBS program according to the Jeffrey Modell Centers Network (JMCN, calculated in USD 5 in the USA per test). The use of the kit increases costs by 21-fold. These data emphasize the need of adjusting the protocols for standardizing the TRECs in our country according to the JMCN. We also extrapolate the cost-effective balance of the TRECs testing in Medellin. Considering that the 2013 live birth number in our city was calculated in 27,569 (according to Departamento Administrativo Nacional de Estadística-DANE) and assuming that the DGS incidence in the city is similar to that calculated in the USA, the NBS would detect approximately 9 cases per year. The cost of the NBS program, taking into account an individual screening value of USD 5 in the USA, would be USD 137,845. Taking into account that the cost of an individual HSCT together with the post-transplant care is approximately USD 320,000, the cost for the annual NBS program plus curative treatment for lymphopenias in Medellín would be approximately USD 3,017,845. By contrast, if newborns with a possible T-cell lymphopenia are not screened at birth, they will develop infections requiring prolonged hospitalization and special treatment with an estimated cost of USD 2,000,000 per year. Thus, the total annual health care costs for the 9 calculated affected newborns with lymphopenia in Medellín would amount to USD 18 million, representing a 5.9 fold increase for the system. Moreover, an undiagnosed child suffering from lymphopenia would hopelessly die in the first five years of live, decreasing the statistics for childhood wellbeing in Colombia, a good indicator of country development. Conclusions: Our results will demonstrate that is profitable and cost-effective to adopt NBS programs for T-cell lymphopenias in Medellín despite administrative and logistics restrictions and more importantly, the educational limitations of the health care agencies and medical community, that have not experienced the advantages of disease prevention and promptly management in primary immunodeficiencies. We pretend to expand this initiative for the early diagnosis of other rare diseases and to establish procedures for the early treatment and complications prevention of affected patients by personalized medicine strategies. Conflict of interest: The authors declare that they have no conflict of interest.

  • [Variation in NK cell number and function in individuals with recurrent or severe infections].

    by Isaura P Sánchez, Lucía C Leal-Esteban, Julio C Orrego-Arango, Carlos G Garcés-Samudio, Ruben Darío Gómez-Arias, Jose Luis Franco, Claudia M Trujillo-Vargas

    The information about defects affecting natural killer cell (NK) development and activity in patients with an abnormal increase of recurrent infections is scarce. To perform a systematic analysis of NK abnormalities in patients with recurrent infections. Our study enrolled twenty patients with severe or recurrent viral infections. Natural killer cell subsets, surface receptors expression and cytotoxicity were analyzed. Results were compared with those from age- and sex-matched healthy controls. Transient alterations were observed in the percentages and absolute numbers of NK cells in patients with infection active episodes. We also described five patients with stable disturbances in the distribution of NK cell subpopulations. These defects are mainly due to a decrease in the CD56 dim CD16 bright cells in peripheral blood. In addition, NK cell function abnormalities were observed in some patients, however, those were always transient and mainly associated to active disease. These findings demonstrate transient alterations in the percentages and absolute numbers of NK cells in patients with recurrent or severe infection. Also, stable disturbances in CD56 dim CD16 bright NK cells are observed in these patients. Nevertheless, these parameters must be thoroughly studied to determine the mechanisms that entail these immune abnormalities and investigate how they alter the immune response.